Table 5.
Multivariate Linear regression model of post-vaccine limitation after 1st & 2nd dose of Comirnaty®
| Model after 1st dose | ||||
|---|---|---|---|---|
| Coef. | CI 95% | P Wald | ||
| Age (each year) | 0.0016 | 0.001 to 0.002 | <0.001 | |
| Male Sex | -0.34 | -0.62 to - 0.05 | 0.021 | |
| Charlson Index | 0.35 | 0.05 to 0.65 | 0.020 | |
| Previous COVID-19 | 0.61 | 0.27 to 0.95 | <0.001 | |
| Isolation due to COVID-19 contact | 0.47 | 0.09 - 0.84 | 0.015 | |
| Model after 2nd dose | ||||
| Coef. | CI 95% | P Wald | ||
| Age (each year) | 0.00003 | -0.001 to 0.001 | 0.963 | |
| Male Sex | -0.20 | -0.60 to 0.20 | 0.332 | |
| Charlson Index | -0.04 | -0.45 to 0.38 | 0.859 | |
| Previous COVID-19 | -0.55 | -1.03 to -0.06 | 0.027 | |
| Isolation due to COVID-19 contact | -0.11 | -0.64 to 0.42 | 0.687 | |
| Functional limitation after 1st dose (0 to 5) | 0.48 | 0.31 to 0.64 | <0.001 | |